Stocks-ABBV-AbbVie Inc

ABBV AbbVie Inc

153.67 -3.10 (-1.98%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest

Performance

0.46% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
271.9B
Day’s Range
153.41
-
156.59
52W Range
133.91
-
175.72
Volume (3M)
6.32M
Price-Earnings Ratio
23.17
Revenue
58.05B

AbbVie Inc Latest News

View All
Top Discussions
John Delves
Edited
✈ 𝙃𝙤𝙡𝙙𝙞𝙣𝙜 𝘿𝙞𝙫𝙞𝙙𝙚𝙣𝙙𝙨 𝙛𝙤𝙧 𝙋𝙖𝙨𝙨𝙞𝙫𝙚 𝙄𝙣𝙘𝙤𝙢𝙚 ✈ 🔊 Week in Review (Weekly Update 1/2) This week, headlines were dominated by the fallout of SVB's collapse last Friday and the subsequent fear of 'contagion' for other banks this week. Financial companies showed... Show More
Like CommentShare
2 replies
null
.
Bjorn Crienen
Learn with me post 1.11! 📚🤓 🟢 Level: Beginner ⚙️ Today we’ll be exploring a topic that is easy to understand and belongs to the very basics of investing! 👉🏼 Today’s topic: Payout Ratio 👉🏼 What is a payout ratio? The payout ratio is a financial metric showing the proportion of earnings a... Show More
Like CommentShare
null
.
Frederick Philippe Alain Jean Luc Comman
United Kingdom
Dear copiers, February portfolio update for Stock: The portfolio is down by -1.88% for this month. February portfolio update for Dividends: The portfolio is up by 18.36% YOY. Principal Dividends received in February : $ACS.MC (ACS) (ACS), $ABBV (AbbVie Inc) (AbbVie inc), $C (Citigroup) (City... Show More
Roman Ondreicka
Edited
Dividends for our portfolio ! $ABBV (AbbVie Inc) 1.48$ per share ex div date 13.4 Paydate 15.5 Forward dividend yield 3.94% $NEE (NextEra Energy Inc) 0.4675 $ per share ex div date 27.2 Paydate 15.3 Forward dividend yield 2.47% 10 % increase from prior dividend of 0.4250... Show More
Like CommentShare
null
.
Esther Cenzano
Hi Copiers, 🙋🏻‍♀️ Today our portfolio received dividend payment from: ⚡️Stock: $JNJ (Johnson & Johnson) ⚡️Stock Exchange/Index: NYSE / $SPX500 / $DJ30 ⚡️Sector: Healthcare ⚡️Industry: Drug Manufactures - General ⚡️Country: USA ⚡️Market Cap: 400.99B 💵 Dividend Information ⚡️Ex-Dividend Date: February... Show More
Like CommentShare
null
.

About AbbVie Inc

AbbVie Inc. is a global biopharmaceutical company that researches, develops, manufactures, and commercialises medicines and therapies. Incorporated in 2012, it has its headquarters in North Chicago, Illinois. AbbVie primarily offers products that address issues in the immunology, oncology, neuroscience, women's health, eye care, and aesthetics areas. The company's immunology products include Humira, Rinvoq, and Skyrizi; products in the oncology field include Venclexta and Imbruvica; aesthetics products include the Juvederm collection and Botox Cosmetic. AbbVie also produces Restasis, Alphagam, and Lumigan for eye care and Orilissa and Lo Loestrin for women's health, as well as Botox Therapeutic, Vraylar, Duodopa, Duopa, and Ubrelvy for the neuroscience field. AbbVie sells its products directly to distributors, wholesalers, healthcare facilities, government agencies, and independent retailers. Listed on the NYSE, AbbVie stock is available under the ticker ABBV. As of December 2021, AbbVie has approximately 48,000 employees working across more than 70 countries. On 10 May 2021, the company announced that its Allergan Aesthetics subsidiary would acquire Soliton, the maker of RESONIC, an FDA-approved Rapid Acoustic Pulse device. This acquisition expands Allergan Aesthetic's body contouring treatment portfolio. The deal was reported to be worth approximately $550m. Track ABBV share price movements by adding it to your eToro watchlist.
50K
Employees
North Chicago, Illinois, US
HQ
2011
Founded
Richard A. Gonzalez
CEO
Show More

Upcoming Earnings

28
APR
REPORTS
AbbVie Inc Q1 2023 earnings report is expected to be released before market open

Analyst Forecast

Consensus
Moderate Buy
Price Target
170.25

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
56
High
Industry 
Avg. 47 
66
Environment
66
Social
45
Governance

People Also Bought